LeadIQ logo
Learn more at LeadIQ.com

Insights

Growth Potential Amaranth Medical has secured a Series B financing of 20 million and an overall funding total of 28 million, indicating active investor interest and potential for accelerated product development, clinical trials, or market expansion opportunities.

Acquisition Edge Now part of R3 Vascular, Amaranth Medical can leverage expanded distribution channels, cross-selling options, and enhanced credibility to target larger hospital systems and integrated delivery networks.

Mid-Sized Focus With a lean team size of 11-50, the company likely prioritizes niche, high-margin medical device solutions; this creates opportunities for RDCs, contract manufacturing, and streamlined procurement partnerships.

Tech Leverage Utilization of modern cloud, web, and UI/UX tech stacks suggests potential for digital health companion tools, device connectivity, data analytics, and remote monitoring offerings to complement core devices.

Market Position Comparable peers in the medtech space demonstrate scale, yet Amaranth’s revenue range and acquisition status imply a target for strategic alliances, co-development deals, and enterprise sales to large healthcare suppliers.

Similar companies to Amaranth Medical, Inc. (Acquired by R3 Vascular)

Amaranth Medical, Inc. (Acquired by R3 Vascular) Tech Stack

Amaranth Medical, Inc. (Acquired by R3 Vascular) uses 8 technology products and services including Consentmanager.net, WordPress, Font Awesome, and more. Explore Amaranth Medical, Inc. (Acquired by R3 Vascular)'s tech stack below.

  • Consentmanager.net
    Consent Management
  • WordPress
    Content Management System
  • Font Awesome
    Font Scripts
  • Google Fonts API
    Font Scripts
  • Google Cloud
    Infrastructure As A Service
  • Onsen UI
    Software Development
  • Bootstrap
    UI Frameworks
  • Nginx
    Web Servers

Amaranth Medical, Inc. (Acquired by R3 Vascular)'s Email Address Formats

Amaranth Medical, Inc. (Acquired by R3 Vascular) uses at least 3 email formats:
Amaranth Medical, Inc. (Acquired by R3 Vascular) Email FormatsExamplePercentage
FLast@amaranthmedical.comJDoe@amaranthmedical.com
83%
First@amaranthmedical.comJohn@amaranthmedical.com
9%
First.Last@amaranthmedical.comJohn.Doe@amaranthmedical.com
8%

Frequently Asked Questions

What is Amaranth Medical, Inc. (Acquired by R3 Vascular)'s phone number?

Minus sign iconPlus sign icon You can contact Amaranth Medical, Inc. (Acquired by R3 Vascular)'s main corporate office by phone at
+1-650-965-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Amaranth Medical, Inc. (Acquired by R3 Vascular)'s official website and social media links?

Minus sign iconPlus sign iconAmaranth Medical, Inc. (Acquired by R3 Vascular)'s official website is amaranthmedical.com and has social profiles on LinkedIn.

How much revenue does Amaranth Medical, Inc. (Acquired by R3 Vascular) generate?

Minus sign iconPlus sign icon As of July 2026, Amaranth Medical, Inc. (Acquired by R3 Vascular)'s annual revenue is estimated to be $1M - $10M.

What is Amaranth Medical, Inc. (Acquired by R3 Vascular)'s NAICS code?

Minus sign iconPlus sign iconAmaranth Medical, Inc. (Acquired by R3 Vascular)'s NAICS code is 33911 - Medical Equipment and Supplies Manufacturing.

How many employees does Amaranth Medical, Inc. (Acquired by R3 Vascular) have currently?

Minus sign iconPlus sign iconAs of July 2026, Amaranth Medical, Inc. (Acquired by R3 Vascular) has approximately 11 employees across 3 continents, including North America, Asia and Europe. Key team members include Vice President Product Development: E. E., Senior Material Scientist: L. W. and : E. C. Explore Amaranth Medical, Inc. (Acquired by R3 Vascular)'s employee directory with LeadIQ.

What industry does Amaranth Medical, Inc. (Acquired by R3 Vascular) belong to?

Minus sign iconPlus sign iconAmaranth Medical, Inc. (Acquired by R3 Vascular) operates in the Medical Devices industry.

What technology does Amaranth Medical, Inc. (Acquired by R3 Vascular) use?

Minus sign iconPlus sign iconAmaranth Medical, Inc. (Acquired by R3 Vascular)'s tech stack includes Consentmanager.net, WordPress, Font Awesome, Google Fonts API, Google Cloud, Onsen UI, Bootstrap and Nginx.

What is Amaranth Medical, Inc. (Acquired by R3 Vascular)'s email format?

Minus sign iconPlus sign iconAmaranth Medical, Inc. (Acquired by R3 Vascular)'s email format typically follows the pattern of FLast@amaranthmedical.com. Find more Amaranth Medical, Inc. (Acquired by R3 Vascular) email formats with LeadIQ.

How much funding has Amaranth Medical, Inc. (Acquired by R3 Vascular) raised to date?

Minus sign iconPlus sign icon As of July 2026, Amaranth Medical, Inc. (Acquired by R3 Vascular) has raised $28M in funding. The last funding round occurred on Oct 08, 2013.
Amaranth Medical, Inc. (Acquired by R3 Vascular) logo

Amaranth Medical, Inc. (Acquired by R3 Vascular)

Medical DevicesCalifornia, United States11-50 Employees

Amaranth Medical, Inc. is a medical device manufacturer based in Mountain View, California. The company operates in the medical equipment manufacturing sector and develops and produces devices for the healthcare field. It is a small to mid-sized enterprise that has been acquired by R3 Vascular. Details about its customers, target markets, or the specific medical applications of its devices are not provided in the available information. The company’s location places it within the United States medical device industry, in an ecosystem with other established firms in this field. Information about the founding date or product lines is not included in the supplied description.

Section iconCompany Overview

Phone number
+1-650-965-****
Website
amaranthmedical.com
NAICS Code
33911 - Medical Equipment and Supplies Manufacturing
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $28M

    Amaranth Medical, Inc. (Acquired by R3 Vascular) has raised a total of $28M of funding over 3 rounds. Their latest funding round was raised on Oct 08, 2013 as a Series B.

  • $1M - $10M

    Amaranth Medical, Inc. (Acquired by R3 Vascular)'s revenue is estimated to be in the range of $1M - $10M

Company Leadership

  • Vice President Product Development at Amaranth Medical, Inc. (Acquired by R3 Vascular)
    E. E.
    Vice President Product Development
    Mobile Phone
  • Senior Material Scientist at Amaranth Medical, Inc. (Acquired by R3 Vascular)
    L. W.
    Senior Material Scientist
    Mobile Phone
  • Employee at Amaranth Medical, Inc. (Acquired by R3 Vascular)
    E. C.
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.